Kelly CRISPR & Gene Editing Technology ETF (XDNA)
Kelly CRISPR & Gene Editing Technology ETF (XDNA) reported 25 holdings in its SEC Form NPORT-P for the period ended 2023-11-30.
No stock price history for XDNA on this site yet.
SEC Form NPORT-P as filed (series S000073961), accession 0001145549-24-002777.
Similar ETFs
| ETF Name | Country | Net Assets | Overlap |
|---|---|---|---|
| Putnam BioRevolution ETF (SYNB) | 16.34% | ||
| Direxion Nanotechnology ETF (TYNE) | 16.21% | ||
| iShares U.S. Healthcare ETF (IYH) | United States | $2.802B | 13.27% |
| State Street(R) Health Care Select Sector SPDR(R) ETF (XLV) | United States | $38.604B | 13.11% |
| John Hancock Multifactor Healthcare ETF (JHMH) | 13.05% | ||
| Fidelity MSCI Health Care Index ETF (FHLC) | United States | $2.854B | 12.62% |
| VANGUARD HEALTH CARE INDEX FUND (VHCIX) | United States | $20.268B | 12.61% |
| VANGUARD HEALTH CARE INDEX FUND (VHT) | United States | $20.268B | 12.61% |
| JPMorgan Healthcare Leaders ETF (JDOC) | United States | $0.011B | 12.21% |
| Tema Heart & Health ETF (HRTS) | United States | $0.055B | 11.90% |